Published June 6, 2020 | Version 0.0

Resonance energy transfer sensitizes and monitors in situ switching of LOV2-based optogenetic actuators

  • 1. Neuronal Signalling Lab, Turku Bioscience Centre, University of Turku and Åbo Academy University, Biocity, Turku, Finland; Turku Screening Unit, Biocity, Turku, Finland
  • 2. Neuronal Signalling Lab, Turku Bioscience Centre, University of Turku and Åbo Academy University, Biocity, Turku, Finland
  • 3. Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Frankfurt, Germany

Description

Engineered light-dependent switches provide uniquely powerful opportunities to investigate and control cell regulatory mechanisms. Existing tools offer high spatiotemporal resolution, reversibility and repeatability. Yet cellular optogenetics applications remain limited in practice. Validation difficulties constrain most usage to easily verified protein translocation rather than inhibition of diffusible targets. Blue light levels commonly needed for actuation can be cytotoxic, precluding long-term experiments. We describe a simple approach overcoming these obstacles. Resonance energy transfer with an adjacent chromophore modulates actuation sensitivity over a 7-fold range. This simultaneously offers on-line monitoring of light-dependent switching and precise quantification of activation-relaxation properties in intact living cells. Applying this approach to different LOV2-based switches reveals relaxation times up to 11-fold faster than anticipated. In situ–measured parameter values guide the design of target-inhibiting actuation trains with minimal blue-light exposure, and context-based optimisation can increase sensitivity and experimental throughput a further 10-fold without loss of temporal precision.

Notes

Manuscript post-review cycle, addressing editorial requirements Acknowledgements: This work was supported by the Magnus Ehrnrooths Foundation (MJC), the National Cancer Institute Grant R01CA200417 (MJC and LLL), the European Union Erasmus + programme (FMK), and 7th Framework Programme Initial Training Networks FP7-PEOPLE-2013-ITN Project Number 608346 Project 'Brain Imaging Return To Health' r'Birth (AP, LLG), the Academy of Finland (mobility projects 309736 and 324581 to MJC), the DAAD with funds from the German Federal Ministry of Education and Research (57348387 and 57458932 to FF), and by access to the facilities of the Turku Screening Unit, a member of the Biocentre Finland Drug Discovery and Chemical Biology Network. We thank David Kelly (Beckton Dickinson) for assistance with the Pathway 855 instrument maintenance, Michiyuki Matsuda (University of Kyoto) and Guillaume Jacquemet (Åbo Academy University) for generously providing fluorescent protein templates, Elena Tcarenkova (University of Turku) for helpful discussion and James Conway (University of Turku) for critical reading of the manuscript.

Files

Fig1.zip

Files (40.6 GB)

Name Size
md5:b4d4456a988723455e1297cbd9d3edca
12.2 GB Preview Download
md5:5b4d7c595a91c1830c50d55a7bb6370e
22.2 GB Preview Download
md5:6db650acbde2d3f9be42bd69566d00bd
6.2 GB Preview Download